Viewing Study NCT00586495


Ignite Creation Date: 2025-12-24 @ 1:57 PM
Ignite Modification Date: 2025-12-27 @ 9:32 PM
Study NCT ID: NCT00586495
Status: COMPLETED
Last Update Posted: 2013-12-13
First Post: 2007-12-21
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Long-term Extension From RCC Phase II (11515)
Sponsor: Bayer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2005-12
Start Date Type: None
Primary Completion Date: 2008-06
Primary Completion Date Type: ACTUAL
Completion Date: 2008-07
Completion Date Type: ACTUAL
First Submit Date: 2007-12-21
First Submit QC Date: None
Study First Post Date: 2008-01-04
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2009-10-08
Results First Submit QC Date: None
Results First Post Date: 2010-02-02
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2013-11-19
Last Update Post Date: 2013-12-13
Last Update Post Date Type: ESTIMATED